PATENT CLAIM ANALYSIS

Application Number: 16032442
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "309000"]

Abstract:
Disclosed are therapeutic compositions including BA-1076 and/or BA-2057, methods of their use in the treatment of ophthalmological disorders. The therapeutic compositions may further include an IOP-lowering prostaglandin. The methods may further include administration of an IOP-lowering prostaglandin.

Claim (Index 20):
The method of  claim 19 , wherein the method is for treating glaucoma, retinitis pigmentosa, macular degeneration, retinal angiogenesis, corneal blindness, Fuchs' corneal dystrophy, or corneal scarring in the subject.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 95.0
- Lexical Diversity: 1.51852
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15570948', '14403523', '11296116', '14837366', '12154396']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7478621255902883
- 35 USC 102 Novelty (BERT): 0.5145060115929062
- Combined Prediction Score: 0.7245265141905501
- Mean Citation Score: 269.57227
- Max Citation Score: 290.30997
- Similarity Product: 237.7864139720625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test